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Abstract:  
 
In order to improve patient survival and reduce the amount of unnecessary and traumatic 
biopsies, non-invasive detection of cancerous tumours is of imperative and urgent need. 
Multicellular tumour spheroids (MTS) can be used as an ex vivo cancer tumour model, to model 
in vivo nanoparticle (NP) uptake by the enhanced permeability and retention (EPR) effect. 
Surface enhanced spatially offset Raman spectroscopy (SESORS) combines both surface 
enhanced Raman spectroscopy (SERS) and spatially offset Raman spectroscopy (SORS) to 
yield enhanced Raman signals at much greater sub-surface levels. By utilizing a reporter that 
has an electronic transition in resonance with the laser frequency, surface enhanced resonance 
Raman scattering (SERRS) yields even greater enhancement in Raman signal. Using a 
handheld SORS spectrometer with back scattering optics, we demonstrate the detection of live 
breast cancer 3D multicellular tumour spheroids (MTS) containing SERRS active NPs through 
15 mm of porcine tissue. False color 2D heat intensity maps were used to determine tumour 
model location. In addition, we demonstrate the tracking of SERRS-active NPs through porcine 
tissue to depths of up to 25 mm. This unprecedented performance is due to the use of red-
shifted chalcogenpyrylium-based Raman reporters to demonstrate the novel technique of 
surface enhanced spatially offset resonance Raman spectroscopy (SESORRS) for the first time. 
Our results demonstrate a significant step forward in the ability to detect vibrational fingerprints 
from a tumour model at depth through tissue. Such an approach offers significant promise for 
the translation of NPs into clinical applications for non-invasive disease diagnostics based on 
this new chemical principle of measurement.    
 
Introduction:  
 
Non-invasive tumour detection is of vital importance for early cancer diagnosis, resulting in 
improved patient survival. Multicellular tumour spheroids (MTS) are used as tumour models and 
mimic in vivo tumour physiology. In contrast to traditional 2D monolayer cell cultures, these three 
dimensional cell models resemble the 3D in vivo environment more closely, establishing 
characteristic concentration gradients in oxygen, nutrients, and metabolites.1 MTS can be used 
as an ex vivo cancer model, avoiding the need for ethical approval and long term experiments 
associated with in vivo experiments. Termed the enhanced permeability and retention (EPR) 
effect, tumours retain nanoparticles (NPs) in their microenvironments due to poor lymphatic 
drainage. Thus, NP uptake is preferential in cancerous cells over healthy cell lines and NPs are 
frequently used to assist in imaging applications.2 MTS can be grown with a uniform distribution 
of NPs dispersed throughout and can provide a model for NP accumulation in tumours in vivo.3 
MTS models were used here to develop a Raman imaging technique for effective tumour 
detection though tissue depths of several millimeters.   
 
Raman spectroscopy has previously been investigated for tumour detection,4 but is often limited 
to biopsy and cellular samples making it unable to non-invasively detect tumours at depth. 
Spatially offset Raman spectroscopy (SORS) provides a means of non-invasive investigation of 
tissue samples at depth by offsetting the point of collection from the point of laser excitation 
typically in the region of a fHZPPǻ[5,6 Unlike confocal techniques where spectral information  
can be acquired at a particular depth by focusing the laser to a given distance in the z-axis, 
SORS makes use of a spatial offset to probe through the barrier/analyte system.5 SORS has 
shown promise in a number of applications including the detection of counterfeit alcohol,7 
assessment of bone composition8,9 and in the analysis of cancerous calcifications in breast 
tissue.4 We have recently reported the use of a handheld SORS spectrometer for the detection 
of ethanol through up to 21 mm of plastic.10  
 
When a molecule is adsorbed onto a metal NP surface, enhancement in scattering of the 
molecularly specific Raman reporter is observed. The surface enhanced Raman scattering 
(SERS) approach has been shown to yield enhancements several orders of magnitude greater 
than conventional Raman scattering.11 SERS has been applied in numerous applications 
including the sensitive detection of DNA,12 explosives detection,13 and in drug delivery sensing.14 
Furthermore, through surface enhanced resonance Raman spectroscopy (SERRS), it is 
possible to greatly increase the Raman signal generated by the nanotags by using a laser that 
corresponds to an electronic transition of the Raman analyte to produce enhancements in the 
order of 1010 to 1014.15,16 
 
Surface enhanced spatially offset Raman spectroscopy (SESORS) combines the benefits of 
SORS with SERS to achieve greater sample interrogation at depth.17 Using SESORS in a 180o 
back-scattering configuration, nanotags have been used in glucose sensing,18 tracked through 
6.75 mm of tissue,19 and up to 8 mm of bone.20,21 Using SESORS in a transmission geometry, 
bisphosphonates have been tracked in bone through 20 mm of tissue 22 and Stone et al. 
detected signal from nanotags through 45 ± 50 mm of tissue.17 Several reports in the literature 
show the potential to target and image tumours in vivo using functionalized NPs.23,24 Kircher et 
al., functionalised Au nanoprobes with chalcogenpyrylium based dyes and the EGFR targeting 
antibody to successfully detect tumours in vivo using a mouse model.25 Whilst the authors 
reported attomolar limits of detection, little knowledge exists on the ability to detect tumours at 
clinically significant and relevant depths, and therefore the approach presented here provides a 
model to image and thus demonstrate, NP uptake in cancerous cells at notable depth. Here we 
report for the first time the use of NPs for the detection of a 3D breast tumour model buried at 
depths of 15 mm in tissue using a SORS instrument with back scattering optics. This was 
achieved by growing 3D breast cancer tumour models from cells incubated with SERRS active 
gold NPs (AuNPs) and then using the signal enhancing benefits of SERRS, combined with the 
through barrier detection capabilities of SORS, to locate the tumour model at depth using surface 
enhanced spatially offset resonance Raman spectroscopy (SESORRS) for the first time. In 
addition, these SESORRS measurements were carried out using a handheld spectrometer, 
which could potentially be used in a clinical environment. Furthermore, using the SESORRS 
approach, we report a penetration depth of up to 25 mm through tissue; the largest thickness to 
which SERS nanotags have been tracked using a back-scattering configuration. 
 
To achieve the detection of the tumour model at depth using the accumulation of NPs within a 
live 3D tumour model, we used chalcogenpyrylium dyes as resonant Raman reporters in 
combination with SESORRS detection. The absorbance wavelength of chalcogenpyrylium dyes 
can be fine-tuned into the near-infrared (NIR) to create a Raman reporter in resonance with the 
laser excitation wavelength of 830 nm.25 Our previous work has explored the use of red-shifted 
nanomaterials as SERS probes in the NIR by utilizing large AuNPs in conjunction with 
chalcogenpyrylium nanotags.26 Chalcogenpyrylium dyes conjugated to large AuNPs have been 
shown to generate strong SERS responses at picomolar detection levels at 1280 nm27 and 1550 
nm laser excitations.26 The chemical structure of each of the five Raman reporters used are 
shown in Figure 1(a-e). The absorbance wavelengths of the highly Raman active 
chalcogenpyrylium dyes; 676, 823, 959 (Figure 1a-c), are tuned by increasing the number of sp2 
carbons from 1 to 3 to 5 in the aliphatic backbone, thus, the wavelength of absorption is tuned 
to 676, 823 and 959 nm respectively. 26,27 Further fine tuning is achieved through the choice of 
chalcogen atoms in the ring systems, which causes the absorption maximum to redshift. BPE 
(d) and AZPY (e) are non-resonant small molecules commonly used for SERS which were used 
for comparison. SERS spectra for each of these five Raman reporters are shown in the 
supporting information Figure S2. All measurements were carried out using AuNPs with an 
average diameter of 83 nm. Each of the five Raman reporters were added to AuNPs to create 
nanotag solutions with a final dye concentration of 300 nM. The aim was to keep the dye 
concentration as low as possible by exploiting the benefit of using a Raman reporter that is in 
resonance with the laser. With regards to the experimental set up, all measurements were 
carried out using a total exposure time of 10 seconds (2 s integration time, 5 accumulations) at 
an 8 mm offset. The nose cone was fitted to use the instrument in a contact mode setting. The 
handheld instrument used here has a fixed maximum exposure time, therefore it is noted that if 
longer acquisition times were used, the signal to noise ratio may have improved. 
 
 
To investigate the advantage of using resonant molecules for in vivo applications, nanotag 
solutions with each reporter were held in a quartz microcuvette. Porcine tissue samples of a 5 
mm thickness were placed in front of the cuvette and brought into contact with the laser leaving 
no space between the nose cone and the sample (supporting information, Figure S3).  Spectra 
were acquired at an 8 mm spatial offset and truncated and baselined prior to processing. We 
have previously shown that at an 8 mm offset, the greatest level of through barrier detection 
takes place, which is the maximum capability of the instrument.10 The height of the most intense 
peak was then calculated as well as the relative percentage peak intensity (Figure 1f). The 
handheld SORS instrument uses an excitation wavelength of 830 nm and it can be seen clearly 
in Figure 1f that a significant enhancement in signal is generated by the resonant dye 823 
compared to the off resonant molecules. Thus, by using a NIR resonant reporter molecule, 
superior SERRS signal through depth is generated over off resonant reporter molecules and the 
technique of SESORRS for greater through tissue detection is clearly demonstrated.  
 
 
 
 
Figure 1- (a ± e) Chemical structure of dye676, dye823, dye959, BPE and AZPY respectively. (f) Bar chart showing 
average peak intensities of dye676, dye823, dye959, BPE and AZPY at 1598, 1592, 1572, 1201 and 1162 cm -1 
respectively, as well as the relative percentage peak intensity, through 5 mm of tissue. Nanotag solutions were held in 
a cuvette and the cuvette was placed behind tissue samples. Spectra were collected using a handheld SORS instrument 
with 830 nm laser excitation at an 8 mm offset. Peak intensities were obtained by scanning 3 replicate samples, 5 times 
(2 second integration, 5 accumulations). The average peak intensity for each of the 5 dyes is shown and error bars 
represent ± one standard deviation. 
 
MTS were used as a 3D breast cancer tumour model to demonstrate the clinical significance of 
SESORRS for in vivo diagnostics. MCF7 human breast cancer cells were incubated overnight 
with the dye 823 nanotag solution (571 fM of AuNps, total of 7.092 x 1011 AuNp) resulting in 
uptake and accumulation of the nanotags within the cancer cells. MTS were then grown from a 
suspension of these cells using a hanging drop technique by pipetting 20 µL drops of MCF7 
human breast cancer cell suspension onto the lid of a petri dish. They were grown over a period 
of 9 days at 37 °C and 5% CO2 in a humidified incubator to a size <1mm. No reduction in growth 
was observed. It is therefore reasonable to assume that the dyes did not cause cell death since 
cells need to be alive in order to divide and replicate to form MTS models. Previous reports show 
that NPs are homogenously dispersed throughout the MTS.3  
 
As described in figure S4, supporting information, roughly 10 MTS were transferred to a section 
of tissue (a). A 15 mm section of porcine tissue was then placed on top of the tissue layer upon 
which the MTS models were positioned (b). This model simulated the detection of SERRS active 
nanotags in tumours through tissue using the SORS approach. A translational x-y stage with a 
range of 2.54 cm was used to maneuver the tissue samples in steps of 3 mm to create an image 
of 7 x 7 pixels. As per the experimental set up described in Figure S4, supporting information, 
the tissue system was brought into contact with the nose cone, and the z-value remained fixed, 
i.e. the stage was not moved in the z-direction. By fixing the z-direction, and utilising the SORS 
technique, we were able to probe through the tissue barrier to detect the MTS models through 
15 mm of tissue. This was achieved by moving the stage the x-y direction to detect the MTS 
models through the tissue barrier. A false colour 2D SESORRS heat map of the peak intensity 
at 1178 cm-1 was then constructed, Figure 2a. This corresponds to the uptake of dye 823 
nanotags into MTS. Clear discrimination is seen between areas where the MTS were present 
and where they were not (Figure 2a,b). There is a direct correlation between where the MTS 
models containing the SERRS-active nanotags were placed and the observed area of maximum 
intensity on the 2D map, i.e. the area of maximum intensity corresponds to the region in which 
the MTS models were positioned, (Figure S4, supporting information). Similarly, at the point of 
minimum intensity in areas where the MTS models were not present, there was no spectral 
contribution from the dye (Figure 2b). In this instance, the observed spectrum corresponds to 
that of the tissue. Therefore, since we know the precise location of the spheroids in the tissue, 
control spectra can be generated on the same image but away from the MTS deposition point.  
Furthermore, the SERRS-active NPs were contained within the spheroids themselves and 
therefore their location within in the system was known prior to imaging. The number of NPs 
present in each MTS was significantly less than for a bulk sample i.e. a nanotag solution held in 
a cuvette. However, despite this, the extremely sensitive detection of both dye 823 peaks at 
1178 and 1592 cm-1 is confirmed in areas where the nanotags, and hence spheroid tumour 
model, were present (Figure 2b), and thus the successful mapping of MTS through 15 mm of 
tissue using SESORRS was achieved. This proof of concept experiment demonstrates that 
targeted NPs in combination with SESORRS imaging could potentially be used to locate tumour 
at depth in vivo.  
 
 
Figure 2 (a) A false colour xy-2D heat SESORRS map of MTS containing dye823 through 15 mm of tissue. The map was 
constructed using the peak intensity at 1178 cm-1. Measurements were carried out using an xy translational stage in 
step sizes of 3 mm to create an image of 7 x 7 pixels. Spectra were truncated, baselined and smoothed prior to 
processing. A combination surface/contour false colour was used to generate a 2D heat map and show the tracking of 
the MTS through 15 mm of tissue. Clear discrimination is seen between spectra collected at the point of maximum 
intensity where the nanotags were spotted and that collected where the nanotags were not present. (b) The 
corresponding maximum and minimum collected 8 mm offset spectra.  All measurements were carried out using a 2 s 
integration time, 5 accumulations, 830 nm laser excitation wavelength. 
 
In a secondary, but no less significant demonstration of the power of this approach, dye 823 
SERRS-active nanotags were detected through 25 mm of tissue. The nanotags were held in a 
quartz microcuvette (supporting information Figure S3) and placed behind 25 mm of porcine 
tissue. Figure 3 shows the dye 823 reference spectrum and tissue reference spectrum (top and 
bottom). The middle spectrum refers to SESORRS signal collected using an 8 mm offset. Both 
characteristic dye 823 peaks (1178 cm-1 and 1592 cm-1) are detectable by eye with the peak at 
1178 cm-1 having greater distinction due to the lack of spectral overlap from the tissue in the 
1600 cm-1 region. A scaled subtraction was also applied (Figure S5, supporting information). 
This also confirms the detection of dye 823 demonstrating impressive potential of the SESORRS 
approach to detect nanotags through 25 mm of tissue using a back-scattering configuration by 
controlling the SERRS effect to achieve superior depth penetration. In previous collaborations 
with Stone and Matousek non-resonant SERS nanotags were detected through depths of up to 
25 and 50 mm, however this was using a transmission geometry and a benchtop instrument.17 
The results detailed here report the largest thickness that nanotags have been detected through 
using a back-scattering optical approach. Furthermore, all previous reports of SESORS has 
involved a benchtop system and this work highlights the ability of a handheld instrument to detect 
SESORRS signals through large thicknesses of tissue.  
 
 
 
 
Figure 3 - The tracking of dye 823 nanotag solution through 25 mm of tissue. The tissue and dye823 reference spectra 
are shown at the bottom and top respectively. The middle spectrum represents the Raman signal collected at an 8 mm 
offset through 25 mm of tissue. The peak at 1178 cm-1 is easily detectable by eye and the peak at 1592 cm-1 is also 
detectable, albeit to a lesser extent. All measurements were carried out using a 2 s integration time, 5 accumulations, 
830 nm laser excitation wavelength. 
 
Through utilizing powerful chalcogenpyrylium-based Raman reporters for SERRS applications 
in combination with SORS we present the SESORRS technique for the first time, made possible 
through the resonant Raman tags, and report the highly significant and successful detection of 
3D breast tumour models through 15 mm of tissue. To the best of our knowledge this is the first 
report of the detection of 3D tumour models using SESORRS. Furthermore, we show it is 
possible to detect nanotags through up to 25 mm of tissue, which is the largest thickness of 
through barrier detection reported using a back-scattering geometry, in contrast to a 
transmission approach. Previous work in the SESORS field has also involved benchtop 
systems, which are bulky and lack portability. The handheld instrument used in this instance has 
a fixed accumulation, i.e. the instrument permits only a certain maximum exposure time. Thus, 
whilst we would expect to achieve larger depth penetration and improved signal to noise with 
high-end benchtop systems which can facilitate longer acquisition times, particularly when 
resonant reporter molecules are used, the results described here show the excellent potential 
of handheld SORS which is more suited to clinical applications. Through the exploitation of the 
resonance effect, this novel work represents a significant step forward in the detection of 
vibrational fingerprints through tissue samples. Thus, an important step forward in the use of 
handheld back-scattering SESORRS for potential clinical applications including non-invasive 
tumour detection is demonstrated. Future work will focus on targeting and imaging tumours in 
vivo using SESORRS through the use of dual functionalised NPs, i.e NPs functionalised with 
both a reporter molecule and a biomolecule that specifically targets the tumour in vivo. The use 
of a Raman reporter molecule will then facilitate the imaging of diseased tissue at depth due to 
accumulation of biofunctionalised NPs at the tumour site. Investigation of tumour depth location 
is also important and this will be investigated as the imaging capabilities of SORS develops to 
give a better insight into tumour location in vivo.  
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